This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Consiglio Nazionale Delle Ricerche, Istituto Superiore Di Sanita. Active years: 2019.
Company Filing History:
2 out of 324 
1 out of 26 
Years Active: 2019
Title: Elisabetta Mattei: Innovator in Pharmaceutical Research
Introduction
Elisabetta Mattei is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative treatments for various medical conditions. With a total of 3 patents to her name, her work has garnered attention in the scientific community.
Latest Patents
One of her latest patents is focused on non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation. This invention pertains to the use of reverse transcriptase (RT) inhibitor compounds for preparing pharmaceutical compositions aimed at counteracting the loss of cellular differentiation in both tumor and non-tumor pathologies. The compounds are designed to bind to the hydrophobic pocket on the RT subunit p66, with preferred compounds including nevirapine, efavirenz, and delavirdine, along with their corresponding salts and/or pharmaceutically acceptable derivatives. Another significant patent involves compositions and methods for treating muscular dystrophy. This invention features modified human transcription factors that can increase utrophin expression, along with recombinant adeno-associated vectors for delivering these modified factors. The methods outlined in this patent aim to treat muscle diseases, including Duchenne's muscular dystrophy.
Career Highlights
Elisabetta Mattei has worked with esteemed organizations such as the Consiglio Nazionale delle Ricerche and the Istituto Superiore di Sanità. Her career has been marked by a commitment to advancing medical research and developing effective treatments for debilitating conditions.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Claudio Passananti and Nicoletta Corbi. These partnerships have contributed to her innovative research and the successful development of her patents.
Conclusion
Elisabetta Mattei's contributions to pharmaceutical research highlight her role as a leading inventor in the field. Her innovative patents and collaborations reflect her dedication to improving medical treatments and advancing scientific knowledge.